NCT05218499 Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma Status COMPLETED Phase PHASE2/PHASE3
NCT05213624 A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis Status COMPLETED Phase PHASE2
NCT05211947 A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study Status TERMINATED Phase PHASE3
NCT05203289 A Study in Healthy People to Test How 2 Different Formulations of BI 695501 Are Taken up by the Body When Given as an Injection Status COMPLETED Phase PHASE1
NCT05202353 A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver Status RECRUITING Phase PHASE1
NCT05200247 An Expanded Access Trial in Japan to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options Status COMPLETED Phase PHASE3
NCT05199662 Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT Status RECRUITING Phase PHASE3
NCT05199194 Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke Status RECRUITING Phase PHASE3
NCT05183360 A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated Status TERMINATED Phase PHASE1
NCT05183347 A Study in Healthy Japanese Men to Test How Well Different Doses of BI 1291583 Are Tolerated Status COMPLETED Phase PHASE1
NCT05182840 A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease Status COMPLETED Phase PHASE2
NCT05169424 A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase N/A
NCT05162014 To Assess the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes Mellitus Treated With Empagliflozin Status COMPLETED Phase N/A
NCT05161481 A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Status TERMINATED Phase PHASE2
NCT05155332 A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors) Status SUSPENDED Phase PHASE1
NCT05155306 A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without Food Status COMPLETED Phase PHASE1
NCT05151653 A Study to Test How Well Healthy Men Tolerate BI 765250 When Given as an Infusion Into the Vein or as an Injection Under the Skin Status COMPLETED Phase PHASE1
NCT05151640 INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation Status COMPLETED Phase N/A
NCT05140226 Cognitive and Physical Training in Patients With Chronic Obstructive Pulmonary Disease Patients Status COMPLETED Phase NA
NCT05139472 Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction Status COMPLETED Phase PHASE4